[조사 보고서] 세계의 현기증 치료제 시장 2023-2027

■ 영문 제목 : Global Vertigo Drugs Market 2023-2027
	■ 상품코드 : IRTNTR75900-23 ■ 조사/발행회사 : Technavio ■ 발행일 : 2023년 7월 ■ 페이지수 : 약120 ■ 작성언어 : 영문 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (주문후 24시간내) ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD2,500 ⇒환산￦3,375,000	견적의뢰/주문/질문
Enterprise License (기업 열람용)	USD4,000 ⇒환산￦5,400,000	견적의뢰/주문/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 현기증 치료제 시장 2023-2027
현기증 치료제 시장은 2022년부터 2027년까지 5억 5,142만 달러로 성장하며, 예측 기간 동안 5.58%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 현기증 치료제 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 담고 있습니다.
현재 시장 시나리오, 최신 동향 및 촉진 요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 시장을 주도하는 요인은 신흥국의 현기증 치료제 수요 증가, 개발도상국의 의료 시설 증가, 온라인 채널의 보급 확대 등이 있습니다.

Technavio사의 현기증 치료제 시장은 다음과 같이 구분됩니다.

유형별
- 말초성 현기증
- 중추성 현기증

유통 채널별
- 오프라인
- 온라인

지역별
- 북미
- 유럽
- 아시아
- 기타 지역(ROW)

이 연구는 현기증에 대한 디지털 건강 솔루션의 통합이 향후 몇 년 동안 현기증 치료제 시장의 성장을 촉진하는 주요 이유 중 하나로 꼽고 있습니다. 또한, 새로운 현기증 치료제의 출시와 제약회사의 R&D 증가는 시장의 큰 수요로 이어질 것으로 예상되고 있습니다.

이 보고서는 현기증 치료제 시장에 대해 다음과 같은 분야를 다루고 있습니다.
- 현기증 치료제 시장 규모
- 현기증 치료제 시장 예측
- 현기증 치료제 시장 산업 분석

강력한 벤더 분석은 고객이 시장 지위를 향상시킬 수 있도록 돕기 위해 설계되었으며, 이에 따라 이 보고서는 AdvaCare Pharma, Altamira Therapeutics Ltd., Amneal Pharmaceuticals Inc., Endo International Plc, Epic Pharma LLC, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Indicus Pharma, Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., Lupin Ltd., Novartis AG, Otonomy Inc., Pfizer Inc., Sensorion, Sound Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Suven Life Sciences Ltd., Teva Pharmaceutical Industries Ltd., 및 Viatris Inc. 등의 기업 정보가 포함되어 있습니다. 또한 현기증 치료제 시장 분석 보고서에는 시장 성장에 영향을 미치는 향후 동향과 과제에 대한 정보도 포함되어 있습니다. 이는 기업이 전략을 수립하고 다가오는 모든 성장 기회를 활용하는 데 도움이 될 것입니다.

이 조사는 업계 주요 참여자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서는 주요 벤더에 대한 분석과 함께 포괄적인 시장 및 벤더 현황을 제공합니다.

이 보고서는 이익, 가격, 경쟁, 프로모션 등 주요 매개변수를 분석하여 여러 출처의 데이터를 조사, 통합, 요약하는 방식으로 시장의 상세한 모습을 제시합니다. 또한, 주요 산업 영향력자를 식별하여 시장의 다양한 측면을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있는 1차 및 2차에 걸친 광범위한 조사 결과입니다. 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해 완전한 경쟁 환경과 정성적 및 정량적 조사를 통한 면밀한 공급업체 선정 방법 및 분석을 제공합니다.

■ 보고서 개요

1. 개요
2. 세계의 현기증 치료제 시장 현황
3. 세계의 현기증 치료제 시장 규모
4. 과거 시장 규모
5. 파이브 포스 분석
6. 유형별 시장 분석
7. 유통 채널별 시장 분석
8. 고객 현황
9. 지역별 분석
10. 추진 요인/과제/동향
11. 기업 현황
12. 기업 분석
13. 부록

■ 보고서 목차

1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
o 4.1 Global vertigo drugs market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global vertigo drugs market market 2017 – 2021 ($ million)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Peripheral vertigo – Market size and forecast 2022-2027
o Exhibit 34: Chart on Peripheral vertigo – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Peripheral vertigo – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Peripheral vertigo – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Peripheral vertigo – Year-over-year growth 2022-2027 (%)
o 6.4 Central vertigo – Market size and forecast 2022-2027
o Exhibit 38: Chart on Central vertigo – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Central vertigo – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Central vertigo – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Central vertigo – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Offline – Market size and forecast 2022-2027
o Exhibit 48: Chart on Offline – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Offline – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Offline – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Offline – Year-over-year growth 2022-2027 (%)
o 7.4 Online – Market size and forecast 2022-2027
o Exhibit 52: Chart on Online – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Online – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Online – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Online – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 56: Market opportunity by Distribution Channel ($ million)
o Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 63: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 79: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 83: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 87: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 91: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 95: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Altamira Therapeutics Ltd.
o Exhibit 107: Altamira Therapeutics Ltd. – Overview
o Exhibit 108: Altamira Therapeutics Ltd. – Product / Service
o Exhibit 109: Altamira Therapeutics Ltd. – Key offerings
o 12.4 Amneal Pharmaceuticals Inc.
o Exhibit 110: Amneal Pharmaceuticals Inc. – Overview
o Exhibit 111: Amneal Pharmaceuticals Inc. – Business segments
o Exhibit 112: Amneal Pharmaceuticals Inc. – Key news
o Exhibit 113: Amneal Pharmaceuticals Inc. – Key offerings
o Exhibit 114: Amneal Pharmaceuticals Inc. – Segment focus
o 12.5 Endo International Plc
o Exhibit 115: Endo International Plc – Overview
o Exhibit 116: Endo International Plc – Business segments
o Exhibit 117: Endo International Plc – Key news
o Exhibit 118: Endo International Plc – Key offerings
o Exhibit 119: Endo International Plc – Segment focus
o 12.6 Epic Pharma LLC
o Exhibit 120: Epic Pharma LLC – Overview
o Exhibit 121: Epic Pharma LLC – Product / Service
o Exhibit 122: Epic Pharma LLC – Key offerings
o 12.7 F. Hoffmann La Roche Ltd.
o Exhibit 123: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 124: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 125: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 126: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 127: F. Hoffmann La Roche Ltd. – Segment focus
o 12.8 GlaxoSmithKline Plc
o Exhibit 128: GlaxoSmithKline Plc – Overview
o Exhibit 129: GlaxoSmithKline Plc – Business segments
o Exhibit 130: GlaxoSmithKline Plc – Key news
o Exhibit 131: GlaxoSmithKline Plc – Key offerings
o Exhibit 132: GlaxoSmithKline Plc – Segment focus
o 12.9 Indicus Pharma
o Exhibit 133: Indicus Pharma – Overview
o Exhibit 134: Indicus Pharma – Product / Service
o Exhibit 135: Indicus Pharma – Key offerings
o 12.10 Jubilant Pharmova Ltd.
o Exhibit 136: Jubilant Pharmova Ltd. – Overview
o Exhibit 137: Jubilant Pharmova Ltd. – Business segments
o Exhibit 138: Jubilant Pharmova Ltd. – Key news
o Exhibit 139: Jubilant Pharmova Ltd. – Key offerings
o Exhibit 140: Jubilant Pharmova Ltd. – Segment focus
o 12.11 Novartis AG
o Exhibit 141: Novartis AG – Overview
o Exhibit 142: Novartis AG – Business segments
o Exhibit 143: Novartis AG – Key offerings
o Exhibit 144: Novartis AG – Segment focus
o 12.12 Pfizer Inc.
o Exhibit 145: Pfizer Inc. – Overview
o Exhibit 146: Pfizer Inc. – Product / Service
o Exhibit 147: Pfizer Inc. – Key news
o Exhibit 148: Pfizer Inc. – Key offerings
o 12.13 Sensorion
o Exhibit 149: Sensorion – Overview
o Exhibit 150: Sensorion – Product / Service
o Exhibit 151: Sensorion – Key offerings
o 12.14 Sun Pharmaceutical Industries Ltd.
o Exhibit 152: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 153: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 154: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.15 Suven Life Sciences Ltd.
o Exhibit 155: Suven Life Sciences Ltd. – Overview
o Exhibit 156: Suven Life Sciences Ltd. – Product / Service
o Exhibit 157: Suven Life Sciences Ltd. – Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 158: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 159: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 160: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 161: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 162: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Viatris Inc.
o Exhibit 163: Viatris Inc. – Overview
o Exhibit 164: Viatris Inc. – Business segments
o Exhibit 165: Viatris Inc. – Key news
o Exhibit 166: Viatris Inc. – Key offerings
o Exhibit 167: Viatris Inc. – Segment focus
13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global vertigo drugs market market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Peripheral vertigo – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Peripheral vertigo – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Peripheral vertigo – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Peripheral vertigo – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Central vertigo – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Central vertigo – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Central vertigo – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Central vertigo – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Offline – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Offline – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Offline – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Offline – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Online – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Online – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Online – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Online – Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Distribution Channel ($ million)
Exhibits57: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Altamira Therapeutics Ltd. – Overview
Exhibits108: Altamira Therapeutics Ltd. – Product / Service
Exhibits109: Altamira Therapeutics Ltd. – Key offerings
Exhibits110: Amneal Pharmaceuticals Inc. – Overview
Exhibits111: Amneal Pharmaceuticals Inc. – Business segments
Exhibits112: Amneal Pharmaceuticals Inc. – Key news
Exhibits113: Amneal Pharmaceuticals Inc. – Key offerings
Exhibits114: Amneal Pharmaceuticals Inc. – Segment focus
Exhibits115: Endo International Plc – Overview
Exhibits116: Endo International Plc – Business segments
Exhibits117: Endo International Plc – Key news
Exhibits118: Endo International Plc – Key offerings
Exhibits119: Endo International Plc – Segment focus
Exhibits120: Epic Pharma LLC – Overview
Exhibits121: Epic Pharma LLC – Product / Service
Exhibits122: Epic Pharma LLC – Key offerings
Exhibits123: F. Hoffmann La Roche Ltd. – Overview
Exhibits124: F. Hoffmann La Roche Ltd. – Business segments
Exhibits125: F. Hoffmann La Roche Ltd. – Key news
Exhibits126: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits127: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits128: GlaxoSmithKline Plc – Overview
Exhibits129: GlaxoSmithKline Plc – Business segments
Exhibits130: GlaxoSmithKline Plc – Key news
Exhibits131: GlaxoSmithKline Plc – Key offerings
Exhibits132: GlaxoSmithKline Plc – Segment focus
Exhibits133: Indicus Pharma – Overview
Exhibits134: Indicus Pharma – Product / Service
Exhibits135: Indicus Pharma – Key offerings
Exhibits136: Jubilant Pharmova Ltd. – Overview
Exhibits137: Jubilant Pharmova Ltd. – Business segments
Exhibits138: Jubilant Pharmova Ltd. – Key news
Exhibits139: Jubilant Pharmova Ltd. – Key offerings
Exhibits140: Jubilant Pharmova Ltd. – Segment focus
Exhibits141: Novartis AG – Overview
Exhibits142: Novartis AG – Business segments
Exhibits143: Novartis AG – Key offerings
Exhibits144: Novartis AG – Segment focus
Exhibits145: Pfizer Inc. – Overview
Exhibits146: Pfizer Inc. – Product / Service
Exhibits147: Pfizer Inc. – Key news
Exhibits148: Pfizer Inc. – Key offerings
Exhibits149: Sensorion – Overview
Exhibits150: Sensorion – Product / Service
Exhibits151: Sensorion – Key offerings
Exhibits152: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits153: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits154: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits155: Suven Life Sciences Ltd. – Overview
Exhibits156: Suven Life Sciences Ltd. – Product / Service
Exhibits157: Suven Life Sciences Ltd. – Key offerings
Exhibits158: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits159: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits160: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits161: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits162: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits163: Viatris Inc. – Overview
Exhibits164: Viatris Inc. – Business segments
Exhibits165: Viatris Inc. – Key news
Exhibits166: Viatris Inc. – Key offerings
Exhibits167: Viatris Inc. – Segment focus
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations

※본 조사보고서 [세계의 현기증 치료제 시장 2023-2027] (코드 : IRTNTR75900-23) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 현기증 치료제 시장 2023-2027] 에 대해서 E메일 문의는 여기를 클릭하세요.

*** 아래는 관련 보고서 소개입니다 ***

세계의 습윤 상처 드레싱 시장 (2023~2027) : 폼 드레싱, 하이드로콜로이드 드레싱, 알긴산 드레싱, 필름 드레싱, 기
IRTNTR40537-23 / Technavio / 2022년 12월 / Technavio사는 세계의 습윤 상처 드레싱 시장 규모가 2022년부터 2027년까지 연평균 5.9% 성장하여, 1365.75백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 보고서는 세계의 습윤 상처 드레싱 시장을 조사 대상으로 하여, 개요,...Technavio Announces the Publication of its Research Report - Global Moist Wound Dressings Market 2023-2027Technavio recognizes the following companies as the key players in the global moist wound dressings market: 3M Co., Axio Biosolutions Pvt Ltd, B. Braun SE, Beiersdorf AG, Cardinal Health Inc., Coloplast Corp., ConvaTec Group Plc, DeRoyal...

세계의 디지털 병리학 시장 (2023~2027) : 디지털 슬라이드 스캐너, 소프트웨어
IRTNTR45085-23 / Technavio / 2022년 11월 / Technavio사는 세계의 디지털 병리학 시장 규모가 2022년부터 2027년까지 연평균 13.2% 성장하여, 716.93백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 보고서는 세계의 디지털 병리학 시장에 대해 다방면으로 조사 및 분석하여, 개요,...Global Digital Pathology Market 2023-2027Technavio has been monitoring the digital pathology market and it is poised to grow by $716.93 mn during 2023-2027, accelerating at a CAGR of 13.2% during the forecast period. Our report on the digital pathology market provides a holistic analysis, market size and forecast, trends, growth...

세계의 투석용 일회용 기기 시장 (2023~2027) : 병원 및 진료소, 진단 센터, 재택 간호, 외래 진료 센터
IRTNTR71425-23 / Technavio / 2022년 12월 / Technavio사의 시장 조사 보고서는 세계의 투석용 일회용 기기 시장 규모가 2022년에서 2027년 사이에 2,234.03백만 달러에 이르며, 예측 기간 동안 연평균 6.42% 성장할 것으로 예상하고 있습니다. 본 조사 자료는 세계의 투석용...Global Dialysis Disposable Devices Market 2023-2027 Technavio has been monitoring the dialysis disposable devices market and is forecast to grow by $2234.03 mn during 2022-2027, accelerating at a CAGR of 6.42% during the forecast period. Our report on the dialysis disposable devices market provides a holistic analysis, market size and...

세계의 의약품 수탁 포장 시장 (2023~2027) : 페트병, 블리스터 팩, 파우치, 비경구 용기, 기타
IRTNTR43108-23 / Technavio / 2023년 1월 / Technavio사(테크나비오)의 시장 조사 보고서는 세계의 의약품 수탁 포장 시장 규모가 2022년에서 2027년 사이에 6,006.87백만 달러로 성장하며, CAGR은 12.81% 확대될 것으로 전망하고 있습니다. 또한 본 조사 자료는 세계의 의약품 수탁 포장...Global Pharmaceutical Contract Packaging Market 2023-2027 Technavio has been monitoring the pharmaceutical contract packaging market and is forecast to grow by $6006.87 mn during 2022-2027, accelerating at a CAGR of 12.81% during the forecast period. Our report on the pharmaceutical contract packaging market provides a holistic analysis, market size and...

세계의 심폐 부하 검사 시스템 시장 (2023~2027) : CPET 시스템, 스트레스 심전도, SPECT 시스템, 스트레스 혈압 모니터, 펄스 옥시미터
IRTNTR41564-23 / Technavio / 2023년 1월 / Technavio사(테크나비오)의 시장 조사 보고서는 세계의 심폐 부하 시험 시스템 시장 규모가 2022년에서 2027년 사이에 2,103.24백만 달러에 이르며, 예측 기간 동안 CAGR 6.92% 확대될 것으로 전망하고 있습니다. 또한 본 조사 자료는...Global Cardiopulmonary Stress Testing Systems Market 2023-2027 Technavio has been monitoring the cardiopulmonary stress testing systems market and is forecast to grow by $2103.24 mn during 2022-2027, accelerating at a CAGR of 6.92% during the forecast period. Our report on the cardiopulmonary stress testing systems market provides a holistic analysis,...

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!